We use cookies on our website so it can function correctly. The cookies we use do not store any specific information about you personally and they won’t harm your computer. See our Privacy Policy for more information.

Cookies on hcahealthcare.co.uk

A cookie is a small file which asks permission to be placed on your computer's hard drive. Once you agree, the file is added and the cookie helps analyse web traffic or lets you know when you visit a particular site. Cookies allow web applications to respond to you as an individual. The web application can tailor its operations to your needs, likes and dislikes by gathering and remembering information about your preferences.

We use traffic log cookies to identify which pages are being used. This helps us analyse data about web page traffic and improve our website in order to tailor it to customer needs. We only use this information for statistical analysis purposes.

Overall, cookies help us provide you with a better website, by enabling us to monitor which pages you find useful and which you do not. A cookie in no way gives us access to your computer or any information about you, other than the data you choose to share with us.

Cookie group mandatory

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.
You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

These cookies are required


Record information about choices that you have made, and they also allow us to tailor the website to suit your needs.

• YouTube

These cookies allow the website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced, more personal features. For instance, a website may be able to provide you with local weather reports or traffic news by storing in a cookie the region in which you are currently located.

These cookies can also be used to remember changes you have made to text size, fonts and other parts of web pages that you can customise. They may also be used to provide services you have asked for such as watching a video or commenting on a blog.

The information these cookies collect are anonymised and they cannot track your browsing activity on other websites.

By using our website, you agree that we can place these types of cookies on your device.



Are used to track visitors across website. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers. 

These cookies allow us to advertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf.
All information these cookies collect is aggregated and therefore anonymous. No personal information is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only.

Performance Cookies

Are used to monitor the use of our website. We use a number of tools that monitor visitor behaviour on our website to help us improve our information and services.


Google Analytics | Google Optimize | adiLP | adiVi | Tealium IQ | Infinity Cloud | AdInsight

These cookies collect information about how visitors use our website, for instance which pages visitors go to most often, and if they get error messages from web pages. These cookies don't collect information that identifies a visitor. All information these cookies collect is aggregated and therefore anonymous. It is only used to improve how our website works.

By using our website, you agree that we can place these types of cookies on your device.


April 20, 2018

Stem cell treatment for multiple sclerosis (MS)

There are over 100,000 people in the UK who suffer from multiple sclerosis (MS).The majority of patients present with a relapse-remission pattern of the disease; however, more than 80% will progress to develop disability, with 40% of patients requiring a wheelchair 10 years after diagnosis.

Autologous Haematopoietic Stem Cell Transplantation (AHCST) is being used as an alternative treatment for patients with relapse-remission MS. During this treatment your stem cells are harvested from your body before resetting your immune system and reinfusing your stem cells. This process encourages your immune system to stop attacking itself and the stem cells to repair the damage that has already been done.

London Bridge Hospital is pleased to offer AHCST to MS patients who meet the acceptance criteria to undergo this treatment.

AHSCT process

  1. Cell collection - we encourage the growth of your stem cells through the use of chemotherapy followed by injections of a growth factor (G-CSF), which will be given daily for 10 days to stimulate your stem cell production. Stem cells are then harvested from your body and are sent to a specialist laboratory to be frozen.
  2. Autologous Haematopoietic Stem Cell Transplantation - you will be admitted to the Hospital as an inpatient, where you will stay while undergoing your treatment. At first you will receive a high dose of chemotherapy and immunotherapy, which will take six days to complete. Your harvested stem cells are then thawed and reinfused into your body. After reinfusion the stem cells find their way back to your bone marrow to repopulate this as well as your immune system. You will be monitored to track the recovery of your blood cells and will be discharged when it is medically safe for you to be at home - this usually takes around three weeks.
  3. After the transplant - after discharge you will continue to be closely monitored through regular blood tests and scans. A Clinical Nurse Specialist (CNS) will be on hand to provide any support or answer any quesitons you may have.

How does stem cell treatment for MS work?

Find out more about MS and the process of the Autologous Haematopoietic Stem Cell Transplantation.

Criteria for treatment

You must meet the following criteria to be eligible for treatment:

  • Aged 18-65
  • A firm diagnosis of MS (using the McDonald's criteria) within the last 15 years
  • If you have relapsing MS, documentation to show that treatment with one of the high efficacy disease modifying drugs has been unsuccessful
  • If you have primary, progressive MS (PPMS), a lumbar puncture confirming oligoclonal bands within the spinal fluid
  • Mobility score (EDSS) between 0-6.5 (with or without bilateral assistance, such as two sticks or a rollator frame)
  • Active MS as defined by an MRI showing one enhancing lesion after being off steroids for one month or two or more new T2 lesions within the last 12 months compared to a comparative scan that was done within the last 2 to 3 years
  • Approval from the London MS-AHSCT Collaborative Group

Contact us

If you would like to know more about Autologous Haematopoietic Stem Cell Transplantation for MS contact us today.

020 7089 2017
back to top